Your Launch Plan Is Ready. Your Launch Team Isn’t.
Most biotech leaders understand that launch preparation, building the plan,…
Process Unleashes Innovation
Strategic planning within a company must be interconnected, with a clear…
Medical Affairs Today
The biggest risk for pre-commercial companies is being singularly focused on a…
100 Dots Connected: Reflecting on Eight Years of Conversations
The first edition of "Connecting the Dots" was published on September 29, 2017.…
The “Forcing Function” of JPM
Biopharma companies need to balance many critical priorities, especially those that are pre-commercial.
A Practical Guide to Biopharma Year-End Planning
As summer winds down and vacations (sadly) come to an end, it’s a natural time to shift focus toward the close of the calendar year. Business leaders…
BIO and Boston: The Global Stage and HLYB
Attending a large conference, medical congress, or trade show can be both exhausting and exhilarating. The decision to go in the first place depends…
Season of Transitions
Three notable transitions worthy of reflection at this point in time.
Medical Affairs Is Stepping Into the Future
The energy was palpable at the 2025 Medical Affairs Professional Society (MAPS) Global Annual Meeting. Conversations were expansive, workshops…
The Power of Key Business Questions
In our biopharma world, we frequently hear the term “Key Business Questions (KBQs).” And while it’s often thrown around as a buzzword (or buzz…
The Underappreciated Value of New Product Planning
The value of New Product Planning (NPP) is often overlooked, but it plays a crucial role in the success of drug development projects. By…
Biopharma Annual Planning Success: Close Your Rings Year-Round
How do we think about biopharma annual planning differently? The analogy we will draw on is fitness trackers and apps—built for mindfulness and…
The Power of Target Product Profiles: Three Case Studies
In the biopharma industry, the Target Product Profile (TPP) is a critical tool for guiding the development and commercialization of new drugs.